Testing effectiveness (Phase 2)Study completedNCT05824156What this trial is testingCM-101 in NASH Patients - The SPLASH StudyWho this might be right forNonalcoholic Steatohepatitis ChemomAb Ltd. 23
Not applicableUnknownNCT05128253What this trial is testingCharacterization of the Platelet Inflammatory Response in NAFL and NASHWho this might be right forNASH - Nonalcoholic SteatohepatitisNAFLD Stefania Basili 44
Not applicableStudy completedNCT05073588What this trial is testingEffect of Indo-Mediterranean Diet on Hepatic Steatosis and Fibrosis in NAFLD ChildrenWho this might be right forNon-Alcoholic Fatty Liver Disease Institute of Liver and Biliary Sciences, India 39
Not applicableActive Not RecruitingNCT05165446What this trial is testingNovel MRE Technique to Assess a Risk Factor for Liver CancerWho this might be right forNASH - Nonalcoholic Steatohepatitis Natalie Torok 35
Not applicableStudy completedNCT04004403What this trial is testingAlternate Day Fasting, Exercise, and NAFLDWho this might be right forNon-Alcoholic Fatty Liver DiseaseObesity University of Illinois at Chicago 80
Post-approval studies (Phase 4)Study completedNCT02331589What this trial is testingAnti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic HepatitisWho this might be right forFatigue Chuncheon Sacred Heart Hospital 75
Early research (Phase 1)Ended earlyNCT00808990What this trial is testingThe Effect of Probiotics on Non Alcoholic Fatty Liver DiseaseWho this might be right forLiver Disease Rabin Medical Center 38
Not applicableNot Yet RecruitingNCT07731360What this trial is testingNon-Invasive Diagnostic Panel for MASLD in Children With ObesityWho this might be right forMetabolic Dysfunction-Associated Steatotic Liver DiseasePediatric ObesityInsulin Resistance Syndrome Kayseri City Hospital 180
Not applicableStudy completedNCT06487325What this trial is testingA Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver DiseaseWho this might be right forFatty Liver Disease Ma Zhe 120
Early research (Phase 1)Study completedNCT03674476What this trial is testingAn Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney FunctionWho this might be right forNAFLDNonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis Bristol-Myers Squibb 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04679376What this trial is testingStatins for the Treatment of NASHWho this might be right forNASH - Nonalcoholic Steatohepatitis Mayo Clinic 70
Testing effectiveness (Phase 2)UnknownNCT04702490What this trial is testingStudy to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASHWho this might be right forNASHNASH - Nonalcoholic SteatohepatitisType 2 Diabetes+5 more Metacrine, Inc. 120
Not applicableActive Not RecruitingNCT06366425What this trial is testingScreening for Chronic Liver Diseases in General PopulationWho this might be right forFibrosis, Liver University Hospital, Montpellier 260
Not applicableStudy completedNCT04988204What this trial is testingDiabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver DiseaseWho this might be right forNonalcoholic Fatty Liver Disease Icahn School of Medicine at Mount Sinai 20
Not applicableUnknownNCT05733897What this trial is testingUsing Hydroxychloroquine to Treat Nonalcoholic SteatohepatitisWho this might be right forNonalcoholic Steatohepatitis National Taiwan University Hospital 150
Testing effectiveness (Phase 2)Study completedNCT03205150What this trial is testingEffect of LIK066 on Reduction of Fatty Content in Livers of Obese PatientsWho this might be right forObese Patients With Non-alcoholic Steatohepatitis (NASH) Novartis Pharmaceuticals 107
Testing effectiveness (Phase 2)Study completedNCT03639623What this trial is testingSafety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)Who this might be right forLiver Transplant; ComplicationsNAFLD Zydus Therapeutics Inc. 20
Early research (Phase 1)Study completedNCT03445208What this trial is testingExperimental Medication BMS-986036 Given to Healthy ParticipantsWho this might be right forHepatic CirrhosisLiver FibrosisNonalcoholic Fatty Liver Disease+1 more Bristol-Myers Squibb 30
Not applicableStudy completedNCT04263376What this trial is testingBariatric Surgery-Induced Shift in Gut Microbiome and NAFLDWho this might be right forObesityDiabetes Mellitus, Type 2NAFLD The Cleveland Clinic 18
Testing effectiveness (Phase 2)Ended earlyNCT01842282What this trial is testingAmlexanox for Type 2 Diabetes and ObesityWho this might be right forDiabetes Mellitus Type 2Non Alcoholic Fatty Liver DiseaseObesity University of Michigan 7